>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
放射性32P-磷酸铬胶体治疗H22移植瘤的实验研究
作者:童冠圣1 黄培林1 刘璐2 张丽达3 黄鹰2 
单位:1.东南大学基础医学院病理学系,江苏南京,210009; 2.东南大学现代医学实验中心,江苏南京,210009; 3.东南大学附属中大医院,江苏南京,210009
关键词:32 P-磷酸铬胶体 淋巴结转移 移植瘤 H22肝癌细胞 小鼠 
分类号:R817.8, R-332
出版年·卷·期(页码):2003·22·第五期(293-297)
摘要:

目的:探讨不同剂量的32P-磷酸铬(Cr32PO4)胶体局部注射对小鼠H22移植瘤和区域淋巴结转移灶的治疗作用.方法:建立小鼠H22移植瘤模型14 d后分别给予高、中、低剂量的Cr32PO4胶体瘤体局部注射,观察Cr32PO4胶体的治疗作用及对肿瘤组织和细胞的形态学影响.结果:不同剂量Cr32PO4胶体注射后瘤体局部依次出现红肿、表面苍白、囊性变,水肿消退后爪垫坏死.光镜下瘤体癌细胞呈多边形,大小不一,核大,可见病理分裂像并侵袭达肌层,同侧月国窝和腹股沟淋巴结均出现淋巴结结构破坏,呈现大量癌细胞浸润.治疗早期瘤体和月国窝淋巴结转移灶呈现局灶性坏死,后期移植瘤和淋巴结转移灶肿瘤组织完全坏死,结构破坏,并可见出血灶.电镜下,治疗早期淋巴结转移灶和瘤体中癌细胞线粒体空化,内质网和细胞器少见.治疗后期细胞结构消失,呈现大量细胞碎片、脂肪滴和空泡.结论:Cr32PO4胶体局部给药对肿瘤组织和邻近的淋巴结转移灶具有明显的杀伤作用.

Objective  To study the anticancer effects and morphological influence of the chromic     32  P phosphorus injected to H22 hepatocellular cancer in Km mice.Methods  The high metastatic mice with H22 hepatoma were adopted as animal models.Chromic     32  P phosphorus was injected to the medial site of right pads in mice for treatment.The therapeutic effects were investigated on morphological and ultrastructural changes in both tumor and regional lymph nodes.Results  Under optic microscope neoplamic focus could be found in pads,right popliteal lymph nodes and groin lymph nodes of mice in animal models.The structure of lymph node was destroyed and occupied by hepatoma ascitic cells in samples of partial lymph nodes.As for mice in higher and medium dose groups,the tumor focus localized in right pads and popliteal lymph nodes showed local necrosis 6 days after administration.On the 17th day of treatment,the tumor focus necrostized thoroughly.The normal structure of lymph node disappeared and changed into connective tissue and hemorrhagic focus.Tumor focus scattered in popliteal and groin lymph nodes in lower dose group simultaneously.Ultrastructurally,the tumor cells in lymph node metastasis focus became slightly abnormal on the 1st day after radiation with mitochondria vaculolated and endoplasmic reticulum and other organelles disappeared in cytoplasma.Seven days after administration,only cell debris,lipid droplet and vacuoles were seen.Conclusion  The local administration of chromic  colloids can be used for treatment of the primary tumor,as well as focus of lymphatic metastasis,which results in dramatic anticancer effects.

参考文献:

[1] Siegel H J, LUCK J V, SIEGEL M E. Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging, 1992
[2] TIAN Z M, LIU Z H, KANG G Q. CT-guided stereotactic injection of radionuclide for treatment of brain tumors, 1992
[3] Voges J, STURM V, LEHRKE R. Cystic craniopharyngioma:long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. 1997. doi:10.1097/00006123-199702000-00006
[4] Order S E, SIEGEL J A, PRINCIPATO R. Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer:a phase study, 1996
[5] Lee I. Evaluation of cellular uptake,tumor retention,radiation response,and tumor patho-physiology in experimental solid tumors after an intratumoral infusion of colloidal 32 P, 1997
[6] Firusian N, DEMPKE W. 3.0.CO, 2-H.aspx">An early phase II study of intratumoral 32 P chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases. 1999. doi:10.1002/(SICI)1097-0142(19990215)85:4&lt, 980::AID-CNCR28&gt, 3.0.CO, 2-H
[7] 凌茂英, 高进. 可移植性小鼠腹水癌(H22)实验性淋巴道转移模型的建立, 1984
[8] McFEE A S, ACKERMAN N B, LOKEN M K. The prevention of hepatic metastasis by the use of colloidal suspension of radioactive chromic phosphate, 1963
[9] LEOPOLDO J A, ERDAL B D. Prevention of abdominal metastases after intraperitoneal injection of Yoshida ascites cells:use of a new colloidal 32 P-chromic phosphate, 1968
[10] Liu L, JIANG Z, TENG G J. Clinical and experimental study on regional administration of phosphorus-32 glass microspheres in treating hepatic carcinoma  . 世界胃肠病学杂志(英文版)1999(6)
[11] ZUBILLAGA M B, BOCCIO J R, NICOLINI J O. Use of colloids of chromic [32P] phosphate in treatment of solid tumors. 1996. doi:10.1016/S0969-8051(96)00123-0 

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 405841 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364